Oriana E Hawkins, Ph.D. - ENTvantage Diagnostics - Assay Development Director

Oriana E Hawkins

Ph.D.

ENTvantage Diagnostics

Assay Development Director

Austin, TX | United States

Main Specialties: Biology

Additional Specialties: Immunology, Microbiology, Assay Development

Oriana E Hawkins, Ph.D. - ENTvantage Diagnostics - Assay Development Director

Oriana E Hawkins

Ph.D.

Introduction

Primary Affiliation: ENTvantage Diagnostics - Austin, TX , United States

Specialties:

Additional Specialties:

Research Interests:

Publications

20Publications

595Reads

36Profile Views

263PubMed Central Citations

Human Leukocyte Antigen-Presented Macrophage Migration Inhibitory Factor Is a Surface Biomarker and Potential Therapeutic Target for Ovarian Cancer.

Mol Cancer Ther 2016 Feb 30;15(2):313-22. Epub 2015 Dec 30.

Department of Microbiology and Immunology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma. Pure MHC LLC, Oklahoma City, Oklahoma.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-15-0658DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4747837PMC
February 2016
44 Reads
1 Citation
5.683 Impact Factor

Combining an Aurora Kinase Inhibitor and a Death Receptor Ligand/Agonist Antibody Triggers Apoptosis in Melanoma Cells and Prevents Tumor Growth in Preclinical Mouse Models.

Clin Cancer Res 2015 Dec 7;21(23):5338-48. Epub 2015 Jul 7.

Department of Veterans Affairs, Tennessee Valley Healthcare System, Nashville, Tennessee. Department of Cancer Biology, Vanderbilt University Medical Center, Nashville, Tennessee.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/content/21/23/5338.ful
Web Search
http://clincancerres.aacrjournals.org/content/early/2015/07/
Web Search
http://clincancerres.aacrjournals.org/cgi/doi/10.1158/1078-0
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-15-0293DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4668227PMC
December 2015
20 Reads
5 Citations
8.722 Impact Factor

Detection of human leukocyte antigen biomarkers in breast cancer utilizing label-free biosensor technology.

J Vis Exp 2015 Mar 24(97). Epub 2015 Mar 24.

Experimmune, A Center for Immunotherapeutic Development, Department of Immunotherapeutics and Biotechnology, Texas Tech University Health Sciences Center;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3791/52159DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4401383PMC
March 2015
13 Reads
1 Citation

Mdm2 and aurora kinase a inhibitors synergize to block melanoma growth by driving apoptosis and immune clearance of tumor cells.

Cancer Res 2015 Jan 14;75(1):181-93. Epub 2014 Nov 14.

Tennessee Valley Healthcare System, Department of Veterans Affairs, Vanderbilt University Medical Center, Nashville, Tennessee. Department of Cancer Biology, Vanderbilt University Medical Center, Nashville, Tennessee.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-14-2405DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4286469PMC
January 2015
52 Reads
14 Citations
9.330 Impact Factor

Myeloid IKKβ promotes antitumor immunity by modulating CCL11 and the innate immune response.

Cancer Res 2014 Dec 21;74(24):7274-84. Epub 2014 Oct 21.

Tennessee Valley Healthcare System, Department of Veterans Affairs, Nashville, Tennessee. Department of Cancer Biology, Vanderbilt University School of Medicine, Nashville, Tennessee.

View Article

Download full-text PDF

Source
http://cancerres.aacrjournals.org/cgi/doi/10.1158/0008-5472.
Publisher Site
http://dx.doi.org/10.1158/0008-5472.CAN-14-1091DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4349570PMC
December 2014
27 Reads
15 Citations
9.330 Impact Factor

A novel T-cell receptor mimic defines dendritic cells that present an immunodominant West Nile virus epitope in mice.

Eur J Immunol 2014 Jul 3;44(7):1936-46. Epub 2014 May 3.

Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/eji.201444450DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4107030PMC
July 2014
18 Reads
7 Citations
4.034 Impact Factor

Adaptor protein2 (AP2) orchestrates CXCR2-mediated cell migration.

Traffic 2014 Apr;15(4):451-69

Department of Veterans Affairs, Tennessee Valley Healthcare System, Nashville, TN, 37212, USA; Department of Cancer Biology, Vanderbilt University School of Medicine, Nashville, TN, 37232, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/tra.12154DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3966550PMC
April 2014
7 Reads
3 Citations
4.350 Impact Factor

Passage-dependent cancerous transformation of human mesenchymal stem cells under carcinogenic hypoxia.

FASEB J 2013 Jul 8;27(7):2788-98. Epub 2013 Apr 8.

Department of Biomedical Engineering, Vanderbilt University Medical Center, Nashville, Tennessee 37235, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1096/fj.13-228288DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3688746PMC
July 2013
33 Reads
12 Citations
5.043 Impact Factor

RAF265 inhibits the growth of advanced human melanoma tumors.

Clin Cancer Res 2012 Apr 20;18(8):2184-98. Epub 2012 Feb 20.

Department of Veterans Affairs, Vanderbilt-Ingram Cancer Center and Vanderbilt University School of Medicine, Nashville, Tennessee 37232, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-11-1122DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3724517PMC
April 2012
24 Reads
23 Citations
8.722 Impact Factor

TCR-like biomolecules target peptide/MHC Class I complexes on the surface of infected and cancerous cells.

Int Rev Immunol 2011 Oct-Dec;30(5-6):328-40

Department of Biomedical Sciences and Center for Immunotherapeutic Research, Texas Tech University Health Sciences Center, 1718 Pine, Abilene, TX 79601, USA.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/full/10.3109/08830185.2011.60
Publisher Site
http://dx.doi.org/10.3109/08830185.2011.604880DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3405915PMC
March 2012
4 Reads
10 Citations
4.103 Impact Factor

The dynamic yin-yang interaction of CXCR4 and CXCR7 in breast cancer metastasis.

Breast Cancer Res 2012 Jan 26;14(1):103. Epub 2012 Jan 26.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/bcr3092DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3496126PMC
January 2012
2 Reads
10 Citations

Differential MHC class I expression in distinct leukocyte subsets.

BMC Immunol 2011 Jul 15;12:39. Epub 2011 Jul 15.

Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, 53706 Wisconsin, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2172-12-39DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3155488PMC
July 2011
11 Reads
11 Citations
2.481 Impact Factor

An HLA-presented fragment of macrophage migration inhibitory factor is a therapeutic target for invasive breast cancer.

J Immunol 2011 Jun 22;186(11):6607-16. Epub 2011 Apr 22.

Department of Microbiology and Immunology, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.1003995DOI Listing
June 2011
74 Reads
9 Citations
4.922 Impact Factor

Direct discovery and validation of a peptide/MHC epitope expressed in primary human breast cancer cells using a TCRm monoclonal antibody with profound antitumor properties.

Cancer Immunol Immunother 2010 Apr 25;59(4):563-73. Epub 2009 Sep 25.

Department of Pharmaceutical Sciences, School of Pharmacy, Center for Immunotherapeutic Research, Texas Tech University Health Sciences Center, 1718 Pine Street, Abilene, TX 79601, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-009-0774-8DOI Listing
April 2010
14 Reads
8 Citations
3.941 Impact Factor

Identification of breast cancer peptide epitopes presented by HLA-A*0201.

J Proteome Res 2008 Apr 18;7(4):1445-57. Epub 2008 Mar 18.

University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73104, Pure Protein, LLC, Oklahoma City, Oklahoma 73104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/pr700761wDOI Listing
April 2008
13 Reads
23 Citations
4.250 Impact Factor